<html xmlns="http://www.w3.org/1999/xhtml"> <head> <style type="text/css">
      	     		 
      	    a                          {background : #ffffff; }
      	    article                    {border-style : dotted; border-width : 2px; }
		 	
		 	div                        {background : #ffffcc;}
		 	div.abstract-title         {font-weight : bold ; font-size : 16pt;}
		 	div.ack                    {border-style : solid ; border-color : red; margin : 2em; }
		 	div.article-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.boxed-text             {margin : 5em; border-style : solid;}
		 	div.contrib-group          {margin : 1em; }
		 	div.fig                    {border-style : solid; border-width : 2px; margin : 2em; }
		 	div.funding                {font-weight : bold ; font-size : 16pt;}
		 	div.given-names            {font-style : italic;}
		 	div.intro                  {border-style : inset; margin : 5px;}
		 	div.introduction           {border-style : inset; margin : 5px;}
		 	div.journal-meta           {border-style : solid; border-width : 1 pt; margin 1em;}
		 	div.journal-title-group    {background : #ffeeee;}
		 	div.article-title          {font-weight : bold ; font-size : 18pt;}
		 	div.kwd                    {font-style : italic}
		 	div.meta-name              {font-weight : bold ; font-size : 16pt;}
		 	div.name                   {font-weight : bold;}
		 	div.alt-title              {font-style : italic; font-size : 12px;}
		 	
		 	div.sec                    {border : 2px; margin 5px; padding 2px;}
		 	div.title                  {font-family : courier; font-weight : bold;
		 	                            font-size : 16pt; margin : 5px;}
		 	
		 	div.materials_methods      {border-style : double; margin : 5px; }
		 	div.methods                {border-style : double; margin : 5px; }
		 	
		 	div.results                {border-style : solid; margin : 5px;}
		 	div.background             {border-style : dotted; margin : 5px;}
		 	
		 	div.discussion             {border-style : groove; margin : 5px;}
		 	div.conclusion             {border-style : ridge; margin : 5px;}
		 	div.conclusions             {border-style : ridge; margin : 5px;}
		 	div.supplementary-material {border-style : inset; margin : 5px;}
		 	div.abbreviations          {border-style : double; border-color : red; margin : 5px;}
		 	div.competinginterests     {border-style : double; border-color : blue; margin : 5px;}
		 	div.acknowledgements       {border-style : double; border-color : green; margin : 5px;}
		 	div.authors_contributions   {border-style : double; border-color : purple; margin : 5px;}
		 	
		 	div.publisher              {border-style : outset; margin : 5px;}
		 	div.fn-type-conflict       {background : #f88; }
		 	div.fn-type-con            {background : #ddf; }
		 	div.fn-type-other          {background : #ddd; }
		 	
		 	div.unknown                {background : #ffd;
									 	  border-style : solid;
									 	  border-width : 1px;
									 	  padding : 2 px;}
		 	  
      	    table                      {background : #ffffdd;}
		 	tr                         {background : #ddddff; padding : 1px;}
		 	
		 	span                       {background : #ffcccc;}
		 	
		 	span.citation-author       {font-family : helvetica; background : #ffeeee;}
		 	span.collab                {background : #ddffff; }
		 	span.comment               {font-family : courier; font-size : 6px; background : #ffaaff;}
		 	span.contrib               {background : #ffffff;}
		 	span.corresp               {background : #ddffdd; }
		 	span.doi                   {background : #ffffff;}
		 	span.email                 {font-family : courier; }
		 	span.etal                  {font-style : italic;}
		 	span.fpage                 {font-family : courier;}
		 	span.given-names           {background : #ffffff;}
		 	span.iso-abbrev            {background : #ffffff;}
		 	span.issn-epub             {background : #ffffff;}
		 	span.issn-ppub             {background : #ffffff;}
		 	span.journal-title         {background : #ffffff;}
		 	span.lpage                 {font-family : courier;}
		 	span.mixed-article-title   {font-style : italic ;}
		 	span.nlm-ta                {background : #ffffff;}
		 	span.pmc                   {background : #ffffff;}
		 	span.pmcid                 {background : #ffffff;}
		 	span.pmid                  {background : #ffffff;}
		 	span.publisher             {background : #ffffff;}
		 	span.publisher-id          {background : #ffffff;}
		 	span.publisher-name        {background : #ffffff;}
		 	span.source                {background : #ffffff;}
		 	span.subject               {background : #ffffff;}
		 	span.surname               {background : #ffffff;}
		 	span.volume                {font-family : courier; font-weight : bold;}
		 	span.year                  {font-family : courier ; font-style : italic;}
			</style> </head> <body> <div class="front" title="front"> <div class="journal-meta" tagx="journal-meta" title="journal-meta"><span class="nlm-ta" title="nlm-ta">J Enzyme Inhib Med Chem</span><span class="iso-abbrev" title="iso-abbrev">J Enzyme Inhib Med Chem</span><div class="journal-title-group" tagx="journal-title-group" title="journal-title-group"><span class="journal-title" tagx="journal-title" title="journal-title">Journal of Enzyme Inhibition and Medicinal Chemistry</span></div><span class="issn-ppub" tagx="issn" title="issn-ppub">1475-6366</span><span class="issn-epub" tagx="issn" title="issn-epub">1475-6374</span><div class="publisher" tagx="publisher" title="publisher"><span class="publisher-name" tagx="publisher-name" title="publisher-name">Taylor &amp;amp; Francis</span></div> </div> <div class="article-meta" tagx="article-meta" title="article-meta"><span class="pmcid" title="pmcid"> pmcid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/7822063">7822063</a></span><span class="pmid" title="pmid"> pmid: <a href="http://www.ncbi.nlm.nih.gov/pubmed/33243025">33243025</a></span><span class="doi" title="doi"> doi: <a href="https://dx.doi.org/10.1080/14756366.2020.1847100">10.1080/14756366.2020.1847100</a></span><span class="publisher-id" title="publisher-id">1847100</span><div class="unknown" title="article-version" tag="article-version">
Version of Record</div> <div class="article-categories" title="article-categories">
: <span class="subject" title="subject">Brief Report</span>: <span class="subject" title="subject">Short Communication</span></div> <div class="title-group" tagx="title-group" title="title-group"> <div class="article-title" title="article-title">
Analogues of 2â€²-hydroxychalcone with modified C4-substituents as the inhibitors against human acetylcholinesterase</div> <div class="alt-title" title="alt-title">
S. D. Sukumaran et al.</div> </div> <div class="contrib-group" title="contrib-group"><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sukumaran</span><span class="given-names" tagx="given-names" title="given-names">Sri Devi</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nasir</span><span class="given-names" tagx="given-names" title="given-names">Shah Bakhtiar</span></span><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tee</span><span class="given-names" tagx="given-names" title="given-names">Jia Ti</span></span><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0003-2438-2376</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Buckle</span><span class="given-names" tagx="given-names" title="given-names">Michael J. C.</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Othman</span><span class="given-names" tagx="given-names" title="given-names">Rozana</span></span><a href="#AF0001">a</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0001-5847-8961</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rahman</span><span class="given-names" tagx="given-names" title="given-names">Noorsaadah Abd.</span></span><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lee</span><span class="given-names" tagx="given-names" title="given-names">Vannajan Sanghiran</span></span><a href="#AF0002">b</a></span><span class="contrib" title="contrib"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bukhari</span><span class="given-names" tagx="given-names" title="given-names">Syed Nasir Abbas</span></span><a href="#AF0003">c</a></span><span class="contrib" title="contrib"><span class="contrib-id" tagx="contrib-id" title="contrib-id">https://orcid.org/0000-0002-5650-9119</span><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chee</span><span class="given-names" tagx="given-names" title="given-names">Chin Fei</span></span><a href="#AF0004">d</a><a href="#AN0001" /></span><span class="citation_author_institution" id="AF0001">[a], <span class="institution" title="institution">Faculty of Medicine, Department of Pharmacy, University of Malaya</span><span class="city" tagx="city" title="city">Kuala Lumpur</span><span class="country" tagx="country" title="country">Malaysia</span></span><span class="citation_author_institution" id="AF0002">[b], <span class="institution" title="institution">Faculty of Science, Department of Chemistry, University of Malaya</span><span class="city" tagx="city" title="city">Kuala Lumpur</span><span class="country" tagx="country" title="country">Malaysia</span></span><span class="citation_author_institution" id="AF0003">[c], <span class="institution" title="institution">College of Pharmacy, Jouf University</span><span class="city" tagx="city" title="city">Al-Jouf</span><span class="country" tagx="country" title="country">Kingdom of Saudi Arabia</span></span><span class="citation_author_institution" id="AF0004">[d], <span class="institution" title="institution">Nanotechnology and Catalysis Research Centre, University of Malaya</span><span class="city" tagx="city" title="city">Kuala Lumpur</span><span class="country" tagx="country" title="country">Malaysia</span></span></div> <div class="author-notes" title="author-notes"> <div class="fn-type-" title=""> <p>Supplemental data for this article can be accessed <a href="https://doi.org/10.1080/14756366.2020.1847100"><u>here</u></a>.</p> </div> <div class="corresp" title="corresp"><b>CONTACT</b> Chin Fei Chee <span class="email" tagx="email" title="email">cheechinfei@um.edu.my</span><span class="institution" title="institution">Nanotechnology and Catalysis Research Centre, University of Malaya</span>, <span class="city" tagx="city" title="city">Kuala Lumpur</span><span class="postal-code" tagx="postal-code" title="postal-code">50603</span>, <span class="country" tagx="country" title="country">Malaysia</span></div> </div><span class="pub-date-" title="pub-date-">: <span>2020-11-11</span></span><span class="pub-date-" title="pub-date-">: <span>2021</span></span><span class="volume" tagx="volume" title="volume">36</span><span class="issue" tagx="issue" title="issue">1</span><span class="fpage" tagx="fpage" title="fpage">130</span><span class="lpage" tagx="lpage" title="lpage">137</span><div class="permissions"><span class="copyright" title="copyright">(C) <span class="copyright-holder" tagx="copyright-holder" title="copyright-holder">The Author(s)</span>, <span class="copyright-year" tagx="copyright-year" title="copyright-year">2020</span></span><span class="license" title="license"><span class="license-p" title="license-p">This is an Open Access article distributed under the terms of the Creative Commons Attribution License (<a href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</a>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</span></span></div><a class="self-uri" href="IENZ_36_1847100.pdf" title="self-uri">IENZ_36_1847100.pdf</a><div class="abstract" title="abstract"> <div class="abstract-title" title="abstract-title">
Abstract</div> <div class="title" tagx="title" title="title">
Abstract</div> <p>A series of C4-substituted tertiary nitrogen-bearing 2â€²-hydroxychalcones were designed and synthesised based on a previous mixed type acetylcholinesterase inhibitor. Majority of the 2â€²-hydroxychalcone analogues displayed a better inhibition against acetylcholinesterase (AChE) than butyrylcholinesterase (BuChE). Among them, compound <b>4c</b> was identified as the most potent AChE inhibitor (IC<sub>50</sub>: 3.3â€‰ÂµM) and showed the highest selectivity for AChE over BuChE (ratio &amp;gt;30:1). Molecular docking studies suggested that compound <b>4c</b> interacts with both the peripheral anionic site (PAS) and catalytic anionic site (CAS) regions of AChE. ADMET analysis confirmed the therapeutic potential of compound <b>4c</b> based on its bloodâ€"brain barrier penetrating. Overall, the results suggest that this 2â€²-hydroxychalcone deserves further investigation into the therapeutic lead for Alzheimerâ€™s disease (AD).</p> </div> <div class="abstract" title="abstract"> <div class="title" tagx="title" title="title">
Graphical Abstract</div> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/" /></div>  </div> </div> <div class="kwd-group"> <div class="title" tagx="title" title="title">
Keywords</div> <div class="kwd" title="kwd">
Alzheimerâ€™s disease</div> <div class="kwd" title="kwd">
acetylcholinesterase</div> <div class="kwd" title="kwd">
butyrylcholinesterase</div> <div class="kwd" title="kwd">
chalcones</div> <div class="kwd" title="kwd">
molecular modelling</div> </div> <div class="counts" title="counts"><span class="fig-count" title="fig-count">fig-count: </span><span class="table-count" title="table-count">table-count: </span><span class="page-count" title="page-count">page-count: </span><span class="word-count" title="word-count">word-count: </span></div> </div> </div> <div class="body" title="body"> <div class="intro" title="intro"> <div class="title" tagx="title" title="title">
Introduction</div> <p>Alzheimerâ€™s disease (AD) is the most typical form of dementia among older people which affects a personâ€™s ability to carry out daily activities. About 47 million people live with dementia worldwide and this figure is anticipated to rise to more than 131 million by 2050<a href="#CIT0001"><sup>1</sup></a>. It has been reported that loss of cholinergic transmission is one of the major causes of AD. Therefore, small molecule cholinesterase inhibitors that enhance cholinergic transmission can be used as a remedy for AD. One such example is donepezil hydrochloride (E2020, Aricept<sup>Â®</sup>), which is currently used in the palliative treatment for mild to moderate AD. Analysis of the crystal structure of donepezil in complex with human AChE suggested that the benzyl, piperidine and indanone rings of donepezil are important pharmacophores for binding to the active site<a href="#CIT0002"><sup>2</sup></a>. Subsequently, a great deal of effort has been directed towards identifying potent AChE inhibitors based on the donepezil structure, involving structure-based design and new scaffolds<a href="#CIT0003"><sup>3â€"13</sup></a>.</p> <p>In our previous study, we have identified several 2â€²-hydroxychalcones that inhibited human AChE in the micromolar range and showed some selectivity for BuChE<a href="#CIT0014"><sup>14</sup></a>. Kinetic studies indicated that these compounds were mixed-type inhibitors. Hence, the present study was undertaken to design and synthesise more potent 2â€²-hydroxychalcone derivatives. The synthesised derivatives were evaluated for their <i>inÂ vitro</i> AChE and BuChE inhibitory activities. The Absorption, Distribution, Metabolism, Excretion and Toxicity (ADMET) parameters of these compounds were calculated. In addition, molecular modelling studies were carried out on the active compounds to gain further insight of the protein-ligand interactions.</p> </div> <div class="materials" title="materials"> <div class="title" tagx="title" title="title">
Materials and methods</div> <div class="general" title="sec"> <div class="title" tagx="title" title="title">
General</div> <p>The chemicals and solvents used for synthesis were of analytical grade and were purchased from Sigma-Aldrich or Merck. Analytical thin-layer chromatography (TLC) was carried out on Merck precoated aluminium silica gel sheets (Kieselgel 60 F<sub>254</sub>). Column chromatography was performed with silica gel 60 (230â€"400 mesh) from Merck. UV/fluorescence was measured using Infinite<sup>Â®</sup> M200 PRO multimode reader (Tecan Group Ltd., MÃ¤nnedorf, Switzerland). Melting points were taken on a Stuart melting point apparatus SMP30 (Staffordshire, UK) which has been certified for accuracy of Â± 0.5 at 50â€‰Â°C, Â± 1.0 at 100â€‰Â°C, Â± 2.5 at 360â€‰Â°C by the manufacturer. NMR spectra were obtained using Jeol ECA 400 (400â€‰MHz) (Jeol Ltd., Akishima, Tokyo, Japan) or Bruker Avance III HD (600â€‰MHz) (Bruker Biospin Corp., Billerica, MA). HRMS (ESI) analyses were performed using Agilent 1200 Series or Agilent 6530 Q-TOF (ESI) spectrometer with Agilent Zorbax C-18 column (Agilent Technologies, Santa Clara, CA). Human recombinant AChE and equine BChE were purchased from Sigma-Aldrich (St. Louis, MO).</p> </div> <div class="synthesisof2â€²-hydroxychalconederivatives" title="sec"> <div class="title" tagx="title" title="title">
Synthesis of 2â€²-hydroxychalcone derivatives</div> <p>The syntheses of designed compounds <b>4aâ€"h</b> and <b>8aâ€"f</b> are described in the <a href="https://doi.org/10.1080/14756366.2020.1847100">supplemental data</a>. Their purity was checked by HPLC, <sup>1</sup>H and <sup>13</sup>C-NMR spectroscopy and mass spectrometry. The ADMET parameters of the synthesised compounds were determined using Discovery Studio v3.1 (Accelrys Inc., San Diego, CA) and SwissADME<a href="#CIT0015"><sup>15</sup></a>.</p> <div class="(e)-n,n-diethyl-2-(4-(3-(2-hydroxy-4-methoxyphenyl)-3-oxoprop-1-en-1yl)phenyl)acetamide(4a)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-<i>N</i>,<i>N</i>-diethyl-2-(4-(3-(2-hydroxy-4-methoxyphenyl)-3-oxoprop-1-en-1yl)phenyl)acetamide (4a)</div> <p>Yellow needle; yield 53%; mp 119.9â€"121.0â€‰Â°C. <sup>1</sup>H NMR (400â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 13.38 (1H, s, OH), 7.78 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î²</sub>), 7.75 (1H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.52 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.48 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î±</sub>), 7.25 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 6.40 (1H, dd, <i>J</i>â€‰=â€‰8.0, 2.6â€‰Hz), 6.39 (1H, d, <i>J</i>â€‰=â€‰2.6â€‰Hz), 3.78 (3H, s, OCH<sub>3</sub>), 3.66 (2H, s, â€"CH<sub>2</sub>CO), 3.32 (2H, q, <i>J</i>â€‰=â€‰6.8â€‰Hz, â€"NCH<sub>2</sub>â€"), 3.24 (2H, q, <i>J</i>â€‰=â€‰7.0â€‰Hz, â€"NCH<sub>2</sub>â€"), 1.06 (6H, m, â€"CH<sub>3</sub>); <sup>13</sup>C NMR (100â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 191.84 (C=O), 169.57 (C=O), 166.69, 166.23, 144.07, 138.44, 133.34, 131.26, 129.49, 128.81, 120.03, 114.11, 107.72, 101.10, 55.59 (OCH<sub>3</sub>), 42.43 (â€"N<u>C</u>H<sub>2</sub>â€"), 40.60 (â€"<u>C</u>H<sub>2</sub>CO), 40.32 (â€"N<u>C</u>H<sub>2</sub>â€"), 14.28 (â€"CH<sub>3</sub>), 12.93 (â€"CH<sub>3</sub>). HRMS calc. for [C<sub>22</sub>H<sub>25</sub>NNaO<sub>4</sub>]<sup>+</sup> = [Mâ€‰+â€‰Na]<sup>+</sup> = 390.1681, found = 390.1689.</p> </div> <div class="(e)-n,n-diethyl-2-(4-(3-(2-hydroxy-4,5-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)acetamide(4b)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-<i>N</i>,<i>N</i>-diethyl-2-(4-(3-(2-hydroxy-4,5-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)acetamide (4b)</div> <p>Yellow needles, yield 49%; mp 115.1â€"120â€‰Â°C. <sup>1</sup>H NMR (400â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 13.31 (1H, s, OH), 7.80 (1H, d, <i>J</i>â€‰=â€‰15.3â€‰Hz, H<sub>Î²</sub>), 7.54 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.42 (1H, d, <i>J</i>â€‰=â€‰15.5â€‰Hz, H<sub>Î±</sub>), 7.26 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.18 (1H, s), 6.43 (1H, s), 3.86, 3.84 (3H each, s, OCH<sub>3</sub>), 3.68 (2H, s, â€"CH<sub>2</sub>CO), 3.33 (2H, m, â€"NCH<sub>2</sub>â€"), 3.27 (2H, m, â€"NCH<sub>2</sub>â€"), 1.07 (6H, m, â€"CH<sub>3</sub>); <sup>13</sup>C NMR (100â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 191.49 (C=O), 169.73 (C=O), 161.80, 157.14, 144.16, 141.99, 138.33, 133.43, 129.51, 128.84, 120.20, 112.02, 111.10, 100.85, 56.99 (OCH<sub>3</sub>), 56.21 (OCH<sub>3</sub>), 42.49 (â€"N<u>C</u>H<sub>2</sub>â€"), 40.45 (â€"<u>C</u>H<sub>2</sub>CO),*40.45 (â€"N<u>C</u>H<sub>2</sub>â€"),*14.26 (â€"CH<sub>3</sub>), 12.93 (â€"CH<sub>3</sub>). *Resonance signal overlapped. HRMS calc. for [C<sub>23</sub>H<sub>27</sub>NNaO<sub>5</sub>]<sup>+</sup> = [Mâ€‰+â€‰Na]<sup>+</sup> = 420.1787, found = 420.1798.</p> </div> <div class="(e)-n,n-diethyl-2-(4-(3-(2-hydroxy-4,6-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)acetamide(4c)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-<i>N</i>,<i>N</i>-diethyl-2-(4-(3-(2-hydroxy-4,6-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)acetamide (4c)</div> <p>Yellow needles; Yield 40%; mp 115.5â€"117.2â€‰Â°C. <sup>1</sup>H NMR (400â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 14.23 (1H, s, OH), 7.79 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î²</sub>), 7.67 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î±</sub>), 7.47 (2H, d, <i>J</i>â€‰=â€‰8.3â€‰Hz), 7.22 (2H, d, <i>J</i>â€‰=â€‰8.3â€‰Hz), 6.01 (1H, d, <i>J</i>â€‰=â€‰2.0â€‰Hz), 5.87 (1H, d, <i>J</i>â€‰=â€‰2.0â€‰Hz), 3.83, 3.75 (3H each, s, OCH<sub>3</sub>), 3.35 (2H, s, â€"CH<sub>2</sub>CO), 3.31 (2H, q, <i>J</i>â€‰=â€‰7.0â€‰Hz, â€"NCH<sub>2</sub>â€"), 3.24 (2H, q, <i>J</i>â€‰=â€‰7.0â€‰Hz, â€"NCH<sub>2</sub>â€"), 1.05 (6H, m, â€"CH<sub>3</sub>); <sup>13</sup>C NMR (100â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 192.61 (C=O), 169.71 (C=O), 168.37, 166.24, 162.53, 141.99, 137.73, 134.13, 129.35, 128.61, 127.30, 106.36, 93.84, 91.26, 55.85 (OCH<sub>3</sub>), 55.56 (OCH<sub>3</sub>), 42.43 (â€"N<u>C</u>H<sub>2</sub>â€"), 40.58 (â€"<u>C</u>H<sub>2</sub>CO), 40.32 (â€"N<u>C</u>H<sub>2</sub>â€"), 14.27 (â€"CH<sub>3</sub>), 12.93 (â€"CH<sub>3</sub>). HRMS calc. for [C<sub>23</sub>H<sub>27</sub>NNaO<sub>5</sub>]<sup>+</sup> = [Mâ€‰+â€‰Na]<sup>+</sup> = 420.1787, found = 420.1788</p> </div> <div class="(e)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)phenyl)prop-2-en-1-one(4d)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)phenyl)prop-2-en-1-one (4d)</div> <p>Yellow needles; yield 45%; mp 139.2â€"141.7â€‰Â°C. <sup>1</sup>H NMR (400â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 13.37 (1H, s, OH), 7.77 (1H, d, <i>J</i>â€‰=â€‰16.0â€‰Hz, H<sub>Î²</sub>), 7.74 (1H, d, <i>J</i>â€‰=â€‰9.0â€‰Hz), 7.51 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.47 (1H, d, <i>J</i>â€‰=â€‰16.0â€‰Hz, H<sub>Î±</sub>), 7.26 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 6.40 (1H, dd, <i>J</i>â€‰=â€‰8.0, 2.4â€‰Hz), 6.38 (1H, d, <i>J</i>â€‰=â€‰2.4â€‰Hz), 3.77 (3H, s, OCH<sub>3</sub>), 3.62 (2H, s, â€"CH<sub>2</sub>CO), 3.42 (2H, m, â€"NCH<sub>2</sub>â€"), 3.37 (2H, m, â€"NCH<sub>2</sub>â€"), 1.86 (2H, m, â€"CH<sub>2</sub>â€"), 1.77 (2H, m, â€"CH<sub>2</sub>â€"); <sup>13</sup>C NMR (100â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 191.83 (C=O), 168.57 (C=O), 166.68, 166.23, 144.07, 137.86, 133.37, 131.26, 129.76, 128.78, 120.03, 114.11, 107.71, 101.10, 55.59 (OCH<sub>3</sub>), 46.95 (â€"N<u>C</u>H<sub>2</sub>â€"), 46.05 (â€"N<u>C</u>H<sub>2</sub>â€"), 42.02 (â€"<u>C</u>H<sub>2</sub>CO), 26.13 (â€"CH<sub>2</sub>â€"), 24.35 (â€"CH<sub>2</sub>â€"). HRMS calc. for [C<sub>22</sub>H<sub>23</sub>NNaO<sub>4</sub>]<sup>+</sup> = [Mâ€‰+â€‰Na]<sup>+</sup> = 388.1525, found = 388.1526.</p> </div> <div class="(e)-1-(2-hydroxy-4,5-dimethoxyphenyl)-3-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)phenyl)prop-2-en-1-one(4e)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-1-(2-hydroxy-4,5-dimethoxyphenyl)-3-(4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)phenyl)prop-2-en-1-one (4e)</div> <p>Yellow needles; yield 39%; mp 149.0â€"150.7â€‰Â°C. <sup>1</sup>H NMR (400â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 13.31 (1H, s, OH), 7.81 (1H, d, <i>J</i>â€‰=â€‰15.4â€‰Hz, H<sub>Î²</sub>), 7.54 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.41 (1H, d, <i>J</i>â€‰=â€‰15.5â€‰Hz, H<sub>Î±</sub>), 7.29 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.18 (1H, s), 6.44 (1H, s), 3.87, 3.85 (3H each, s, OCH<sub>3</sub>), 3.63 (2H, s, â€"CH<sub>2</sub>CO), 3.41 (4H, m, â€"NCH<sub>2</sub>â€"), 1.86 (2H, m, â€"CH<sub>2</sub>â€"), 1.81 (2H, m, â€"CH<sub>2</sub>â€"); <sup>13</sup>C NMR (100â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 191.49 (C=O), 169.02 (C=O), 161.80, 157.13, 144.17, 141.99, 137.77, 133.47, 129.80, 128.81, 120.22, 112.02, 111.09, 100.84, 56.99 (OCH<sub>3</sub>), 56.21 (OCH<sub>3</sub>), 46.94 (â€"N<u>C</u>H<sub>2</sub>â€"), 46.29 (â€"N<u>C</u>H<sub>2</sub>â€"), 41.94 (â€"<u>C</u>H<sub>2</sub>CO), 26.11 (â€"CH<sub>2</sub>â€"), 24.43 (â€"CH<sub>2</sub>â€"). HRMS calc. for [C<sub>23</sub>H<sub>24</sub>NO<sub>5</sub>]<sup>âˆ’</sup> = [Mâ€‰âˆ’â€‰H] <sup>âˆ’</sup> 394.1654, found = 394.1678.</p> </div> <div class="(e)-2-(4-(3-(2-hydroxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)aceticacid(4f)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-2-(4-(3-(2-hydroxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)acetic acid (4f)</div> <p>Yellow needles; yield 61%; mp 194.1â€"194.6â€‰Â°C. <sup>1</sup>H NMR (400â€‰MHz, DMSO-d<sub>6</sub>): <i>Î´</i> 12.53 (1H, s, OH), 8.24 (1H, m), 8.01 (1H, d, <i>J</i>â€‰=â€‰15.5â€‰Hz, H<sub>Î²</sub>), 7.84 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.82 (1H, d, <i>J</i>â€‰=â€‰15.5â€‰Hz, H<sub>Î±</sub>), 7.54 (1H, m), 7.35 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.00 (1H, dd, <i>J</i>â€‰=â€‰7.8, 2.4â€‰Hz), 6.98 (1H, d, <i>J</i>â€‰=â€‰2.4â€‰Hz), 3.63 (2H, s, â€"CH<sub>2</sub>CO); <sup>13</sup>C NMR (100â€‰MHz, DMSO-d<sub>6</sub>): <i>Î´</i> 194.09 (C=O), 172.75 (C=O), 162.33, 145.09, 138.71, 136.77, 133.35, 131.29, 130.54, 129.56, 121.84, 121.22, 119.64, 118.20, 41.03 (â€"<u>C</u>H<sub>2</sub>CO). HRMS calc. for [C<sub>17</sub>H<sub>15</sub>O<sub>4</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 283.0970, found = 283.0979.</p> </div> <div class="(e)-2-(4-(3-(2-hydroxy-5-methoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)aceticacid(4g)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-2-(4-(3-(2-hydroxy-5-methoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)acetic acid (4g)</div> <p>Orange powders; yield 44%; mp 91.7â€"93.6â€‰Â°C. <sup>1</sup>H NMR (400â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 12.36 (1H, s, OH), 7.88 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î²</sub>), 7.60 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.55 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î±</sub>), 7.34 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.33 (1H, d, <i>J</i>â€‰=â€‰2.5â€‰Hz), 7.13 (1H, dd, <i>J</i>â€‰=â€‰7.8, 2.5â€‰Hz), 6.96 (1H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 3.83 (3H, s, OCH<sub>3</sub>), 3.76 (2H, s, âˆ’CH<sub>2</sub>CO); <sup>13</sup>C NMR (100â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 193.46 (C=O), 170.65 (C=O), 158.01, 151.80, 145.32, 138.34, 133.30, 129.75, 129.08, 123.99, 120.02, 119.72, 119.44, 113.00, 56.25 (OCH<sub>3</sub>), 40.84 (â€"<u>C</u>H<sub>2</sub>CO). HRMS calc. for [C<sub>18</sub>H<sub>17</sub>O<sub>5</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 313.1071, found = 313.1036.</p> </div> <div class="(e)-2-(4-(3-(2-hydroxy-4,6-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)aceticacid(4h)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-2-(4-(3-(2-hydroxy-4,6-dimethoxyphenyl)-3-oxoprop-1-en-1-yl)phenyl)acetic acid (4h)</div> <p>Yellow powders; yield 58%; mp 139.2â€"141.2â€‰Â°C. <sup>1</sup>H NMR (400â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 14.21 (1H, s, OH), 7.79 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î²</sub>), 7.68 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î±</sub>), 7.48 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.21 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 6.02 (1H, d, <i>J</i>â€‰=â€‰2.2â€‰Hz), 5.88 (1H, d, <i>J</i>â€‰=â€‰2.2â€‰Hz), 3.83, 3.76 (3H each, s, OCH<sub>3</sub>), 3.70 (2H, s, â€"CH<sub>2</sub>CO); <sup>13</sup>C NMR (100â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 192.60 (C=O), 169.01 (C=O), 168.38, 166.26, 162.53, 141.93, 137.53, 134.15, 129.25, 128.68, 127.35, 106.37, 93.85, 91.29, 55.88 (OCH<sub>3</sub>), 55.58 (OCH<sub>3</sub>), 40.79 (â€"<u>C</u>H<sub>2</sub>CO). HRMS calc. for [C<sub>19</sub>H<sub>19</sub>O<sub>6</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 343.1182, found = 343.1194.</p> </div> <div class="(e)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)prop-2-en-1-one(8a)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)prop-2-en-1-one (8a)</div> <p>Yellow solid; yield 67%; mp 166.7â€"169.7â€‰Â°C. <sup>1</sup>H NMR (600â€‰MHz, CDCl<sub>3</sub> (90%) and MeOH-<i>d</i><sub>4</sub> (10%)): <i>Î´</i> 13.45 (1H, brs, OH), 7.76 (1H, d, <i>J</i>â€‰=â€‰15.9â€‰Hz, H<sub>Î²</sub>), 7.74 (1H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.52 (2H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 7.37 (1H, d, <i>J</i>â€‰=â€‰15.4â€‰Hz, H<sub>Î±</sub>), 6.87 (1H, d, <i>J</i>â€‰=â€‰8.0â€‰Hz), 6.40 (1H, d, <i>J</i>â€‰=â€‰7.8â€‰Hz), 6.39 (1H, s), 4.24 (2H, brt, â€"CH<sub>2</sub>â€"), 3.78 (3H, s, OCH<sub>3</sub>), 2.94 (2H, brt, â€"CH<sub>2</sub>â€"), 2.69 (4H, brs, â€"NCH<sub>2</sub>â€"), 1.70 (4H, brs, â€"CH<sub>2</sub>â€"), 1.46 (2H, brs,â€"CH<sub>2</sub>â€"); <sup>13</sup>C NMR (150â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 191.97 (C=O), 166.09, 165.97, 160.01, 143.98, 131.30, 130.35, 128.11, 118.27, 114.95, 114.02, 107.53, 100.96, 63.97 (â€"OCH<sub>2</sub>â€"), 56.70 (â€"CH<sub>2</sub>Nâ€"), 55.45 (â€"NCH<sub>2</sub>â€"), 54.37 (OCH<sub>3</sub>), 23.96 (â€"CH<sub>2</sub>â€"), 22.55 (â€"CH<sub>2</sub>â€"). HRMS calc. for [C<sub>23</sub>H<sub>28</sub>NO<sub>4</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 382.2018, found = 382.2036.</p> </div> <div class="(e)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)prop-2-en-1-one(8b)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-1-(2-hydroxy-4-methoxyphenyl)-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)prop-2-en-1-one (8b)</div> <p>Yellow needles; yield 72%; mp 189.9â€"192.1â€‰Â°C. <sup>1</sup>H NMR (600â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 13.44 (1H, brs, OH), 7.77 (1H, d, <i>J</i>â€‰=â€‰15.0â€‰Hz, H<sub>Î²</sub>), 7.74 (1H, d, <i>J</i>â€‰=â€‰9.0â€‰Hz), 7.53 (2H, d, <i>J</i>â€‰=â€‰8.5â€‰Hz), 7.38 (1H, d, <i>J</i>â€‰=â€‰15.4â€‰Hz, H<sub>Î±</sub>), 6.89 (2H, d, <i>J</i>â€‰=â€‰8.5â€‰Hz), 6.42 (1H, dd, <i>J</i>â€‰=â€‰9.0, 2.0â€‰Hz), 6.39 (1H, s), 4.32 (2H, t, <i>J</i>â€‰=â€‰5.0â€‰Hz, â€"CH<sub>2</sub>â€"), 3.78 (3H, s, OCH<sub>3</sub>), 3.20 (2H, t, <i>J</i>â€‰=â€‰5.0â€‰Hz, â€"CH<sub>2</sub>â€"), 3.02 (4H, brs, â€"NCH<sub>2</sub>â€"), 1.95 (4H, brs, â€"CH<sub>2</sub>â€"); <sup>13</sup>C NMR (150â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 191.88 (C=O), 166.14, 166.10, 159.90, 143.91, 131.26, 130.41, 128.33, 118.46, 115.06, 114.12, 107.62, 101.06, 64.79 (â€"OCH<sub>2</sub>â€"), 55.58 (â€"CH<sub>2</sub>Nâ€"), 54.64 (OCH<sub>3</sub>), 54.25 (â€"NCH<sub>2</sub>â€"), 23.26 (â€"CH<sub>2</sub>â€"). HRMS calc. for [C<sub>22</sub>H<sub>26</sub>NO<sub>4</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 368.1862, found = 368.1885.</p> </div> <div class="(e)-1-(2-hydroxy-4,5-dimethoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)prop-2-en-1-one(8c)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-1-(2-hydroxy-4,5-dimethoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)prop-2-en-1-one (8c)</div> <p>Dark red needles; yield 61%; mp 145.0â€"146.2â€‰Â°C. <sup>1</sup>H NMR (600â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 13.37 (1H, s, OH), 7.78 (1H, d, <i>J</i>â€‰=â€‰15.4â€‰Hz, H<sub>Î²</sub>), 7.54 (2H, d, <i>J</i>â€‰=â€‰8.6â€‰Hz), 7.32 (1H, d, <i>J</i>â€‰=â€‰15.5â€‰Hz, H<sub>Î±</sub>), 7.20 (1H, s), 6.88 (2H, d, <i>J</i>â€‰=â€‰8.6â€‰Hz), 6.43 (1H, s), 4.38 (2H, t, <i>J</i>â€‰=â€‰3.6â€‰Hz, â€"CH<sub>2</sub>â€"), 3.86, 3.85 (3H each, s, OCH<sub>3</sub>), 3.20 (2H, t, <i>J</i>â€‰=â€‰3.0â€‰Hz, â€"CH<sub>2</sub>â€"), 2.99 (4H, brs, â€"NCH<sub>2</sub>â€"), 1.85 (4H, m, â€"CH<sub>2</sub>â€"), 1.54 (2H, brs, â€"CH<sub>2</sub>â€"); <sup>13</sup>C NMR (150â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 191.45 (C=O), 161.73, 159.75, 157.04, 143.96, 141.76, 130.44, 128.43, 118.53, 115.08, 112.04, 111.17, 100.84, 63.83 (â€"OCH<sub>2</sub>â€"), 57.05 (â€"CH<sub>2</sub>Nâ€"), 56.66 (â€"NCH<sub>2</sub>â€"), 56.19 (OCH<sub>3</sub>), 54.44 (OCH<sub>3</sub>), 23.61 (â€"CH<sub>2</sub>â€"), 22.51 (â€"CH<sub>2</sub>â€"). HRMS calc. for [C<sub>24</sub>H<sub>30</sub>NO<sub>5</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 412.2124, found = 412.2130.</p> </div> <div class="(e)-1-(2-hydroxy-4,5-dimethoxyphenyl)-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)prop-2-en-1-one(8d)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-1-(2-hydroxy-4,5-dimethoxyphenyl)-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)prop-2-en-1-one (8d)</div> <p>Orange solid; yield 58%; mp 167.0â€"169.0â€‰Â°C. <sup>1</sup>H NMR (600â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 13.35 (1H, s, OH), 7.78 (1H, d, <i>J</i>â€‰=â€‰15.4â€‰Hz, H<sub>Î²</sub>), 7.55 (2H, d, <i>J</i>â€‰=â€‰8.7â€‰Hz), 7.34 (1H, d, <i>J</i>â€‰=â€‰15.4â€‰Hz, H<sub>Î±</sub>), 7.19 (1H, s), 6.90 (2H, d, <i>J</i>â€‰=â€‰8.7â€‰Hz), 6.44 (1H, s), 4.49 (2H, t, <i>J</i>â€‰=â€‰4.5â€‰Hz, â€"CH<sub>2</sub>â€"), 3.87, 3.86 (3H each, s, OCH<sub>3</sub>), 3.42 (2H, t, <i>J</i>â€‰=â€‰4.6â€‰Hz, â€"CH<sub>2</sub>â€"), 3.33 (4H, brs, â€"NCH<sub>2</sub>â€"), 2.09 (4H, brs, â€"CH<sub>2</sub>â€"); <sup>13</sup>C NMR (150â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 191.43 (C=O), 161.75, 159.37, 157.04, 143.84, 141.96, 130.49, 128.75, 118.74, 115.09, 112.03, 111.09, 100.85, 63.91 (â€"OCH<sub>2</sub>â€"), 57.03 (â€"CH<sub>2</sub>Nâ€"), 56.21 (â€"NCH<sub>2</sub>â€"), 54.55 (OCH<sub>3</sub>), 54.05 (OCH<sub>3</sub>), 23.27 (â€"CH<sub>2</sub>â€"). HRMS calc. for [C<sub>23</sub>H<sub>28</sub>NO<sub>5</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 398.1967, found = 398.1968.</p> </div> <div class="(e)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)prop-2-en-1-one(8e)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-(2-(piperidin-1-yl)ethoxy)phenyl)prop-2-en-1-one (8e)</div> <p>Yellow needles; yield 69%; mp 164.3â€"166.7â€‰Â°C. <sup>1</sup>H NMR (600â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 14.30 (1H, s, OH), 7.73 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î²</sub>), 7.68 (1H, d, <i>J</i>â€‰=â€‰15.6â€‰Hz, H<sub>Î±</sub>), 7.47 (2H, d, <i>J</i>â€‰=â€‰8.4â€‰Hz), 6.85 (2H, d, <i>J</i>â€‰=â€‰8.4â€‰Hz), 6.03 (1H, s), 5.89 (1H, s), 4.28 (2H, t, <i>J</i>â€‰=â€‰5.0â€‰Hz, â€"CH<sub>2</sub>â€"), 3.85, 3.76 (3H each, s, OCH<sub>3</sub>), 2.98 (2H, t, <i>J</i>â€‰=â€‰5.0â€‰Hz, â€"CH<sub>2</sub>â€"), 2.75 (4H, brs, â€"NCH<sub>2</sub>â€"), 1.74 (4H, m, â€"CH<sub>2</sub>â€"), 1.48 (2H, brs, â€"CH<sub>2</sub>â€"); <sup>13</sup>C NMR (150â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 192.55 (C=O), 168.36, 166.09, 162.47, 159.72, 142.13, 130.13, 128.92, 125.56, 114.98, 106.35, 93.83, 91.25, 64.61 (â€"OCH<sub>2</sub>â€"), 57.07 (â€"CH<sub>2</sub>Nâ€"), 55.87 (OCH<sub>3</sub>), 55.58 (â€"NCH<sub>2</sub>â€"), 54.60 (OCH<sub>3</sub>), 24.41 (â€"CH<sub>2</sub>â€"), 23.09 (â€"CH<sub>2</sub>â€"). HRMS calc. for [C<sub>24</sub>H<sub>30</sub>NO<sub>5</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 412.2124, found = 412.2131.</p> </div> <div class="(e)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)prop-2-en-1-one(8f)" title="sec"> <div class="title" tagx="title" title="title">
(<i>E</i>)-1-(2-hydroxy-4,6-dimethoxyphenyl)-3-(4-(2-(pyrrolidin-1-yl)ethoxy)phenyl)prop-2-en-1-one (8f)</div> <p>Yellow solid; yield 70%; mp 157.0â€"159.0â€‰Â°C. <sup>1</sup>H NMR (600â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 14.27 (1H, s, OH), 7.73 (1H, d, <i>J</i>â€‰=â€‰15.5â€‰Hz, H<sub>Î²</sub>), 7.67 (1H, d, <i>J</i>â€‰=â€‰15.5â€‰Hz, H<sub>Î±</sub>), 7.48 (2H, d, <i>J</i>â€‰=â€‰8.6â€‰Hz), 6.89 (2H, d, <i>J</i>â€‰=â€‰8.6â€‰Hz), 6.03 (1H, d, <i>J</i>â€‰=â€‰2.3â€‰Hz), 5.89 (1H, d, <i>J</i>â€‰=â€‰2.3â€‰Hz), 4.50 (2H, t, <i>J</i>â€‰=â€‰4.4â€‰Hz, â€"CH<sub>2</sub>â€"), 3.85, 3.77 (3H each, s, OCH<sub>3</sub>), 3.45 (2H, t, <i>J</i>â€‰=â€‰4.4â€‰Hz, â€"CH<sub>2</sub>â€"), 3.35 (4H, brs, â€"NCH<sub>2</sub>â€"), 2.10 (4H, brs, â€"CH<sub>2</sub>â€"); <sup>13</sup>C NMR (150â€‰MHz, CDCl<sub>3</sub>): <i>Î´</i> 192.52 (C=O), 168.37, 166.17, 162.50, 158.75, 141.71, 130.18, 129.68, 126.10, 115.04, 106.35, 93.85, 91.28, 63.55 (â€"OCH<sub>2</sub>â€"), 55.89 (â€"CH<sub>2</sub>Nâ€"), 55.59 (OCH<sub>3</sub>), 54.54 (OCH<sub>3</sub>), 54.01 (â€"NCH<sub>2</sub>â€"), 23.26 (â€"CH<sub>2</sub>â€"). HRMS calc. for [C<sub>23</sub>H<sub>28</sub>NO<sub>5</sub>]<sup>+</sup> = [Mâ€‰+â€‰H]<sup>+</sup> = 398.1967, found = 398.1973.</p> </div> </div> <div class="enzymeinhibitionstudies" title="sec"> <div class="title" tagx="title" title="title">
Enzyme inhibition studies</div> <p>To determine the inhibitory activity of the target compounds towards cholinesterases, the AChE and BuChE inhibition assays were performed in 96 well plates by the method of Ellman with slight modifications<a href="#CIT0016"><sup>16</sup></a>. First, sodium phosphate buffer (110â€‰Î¼L; pH 8.0) was added into each well followed by 20â€‰Î¼L of each test compound, 50â€‰Î¼L of 5,5â€²-dithiobis-(2-nitrobenzoic acid) (DTNB) (0.126â€‰mM) and 20â€‰Î¼L of AChE or BuChE (0.15 units per mL). Then, the mixture was incubated for 20â€‰min at 37â€‰Â°C. Subsequently, the reaction was initiated by addition of 50â€‰Î¼L (0.120â€‰mM) of the substrate, acetylthiocholine (ATC) iodide or butyrylthiocholine (BTC) iodide (depending on the enzyme). The hydrolysis of ATC or BTC was monitored with an Infinite<sup>Â®</sup> M200 PRO multimode reader (Tecan Group Ltd., MÃ¤nnedorf, Switzerland) by measuring the absorbance of the yellow 5-thio-2-nitrobenzoate anion at 412â€‰nm, every 30â€‰s for 25â€‰min. Donepezil, propidium iodide and tacrine were used as standard inhibitors. Each assay was performed in triplicate. The percentage of inhibition was calculated using the following expression: </p><div class="disp-formula" title="disp-formula"> <div class="alternatives" title="alternatives"> <div class="graphic" position="float" orientation="portrait" /><div class="math_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mrow_UNKNOWN"> <div class="mo_UNKNOWN">
(</div> <div class="mrow_UNKNOWN"> <div class="mi_UNKNOWN">
E</div> <div class="mo_UNKNOWN">
â€"</div> <div class="mi_UNKNOWN">
S</div> </div> <div class="mo_UNKNOWN">
)</div> </div> <div class="mo_UNKNOWN">
/</div> <div class="mi_UNKNOWN">
E</div> <div class="mi_UNKNOWN">
Â </div> <div class="mo_UNKNOWN">
Ã—</div> <div class="mn_UNKNOWN">
100</div> </div></div></div> </div> where E is the activity of the enzyme without test compound and S is the activity of the enzyme with the test compound. IC<sub>50</sub> values were obtained from concentration-inhibition experiments by nonlinear regression analysis using PRISM<sup>Â®</sup> v5.0 (GraphPad Inc., San Diego, CA).<p /> </div> <div class="molecularmodellingstudies" title="sec"> <div class="title" tagx="title" title="title">
Molecular modelling studies</div> <p>Three-dimensional structural models of the test compounds were built using Chem Bio-3D v13 (CambridgeSoft, Cambridge, MA) and saved in MOL2 format. The compounds were then prepared in a protonated form, where appropriate for physiological pH, and minimised using Hyperchem Pro v6.0 (geometry optimisation â€" MM<sup>+</sup>) to give the lowest energy conformation. The X-ray crystal structure of human AChE in complex with donepezil was retrieved from the Protein Data Bank (PDB ID: 4EY7)<a href="#CIT0002"><sup>2</sup></a>. Ligand and water molecules were removed using Discovery Studio v3.1. Hydrogen atoms were added and double coordinates were corrected using Hyperchem Pro v6.0 (Hypercube Inc., Gainesville, FL). Hydrogen atoms were again added, non-polar hydrogen atoms were merged, and missing atoms were repaired using AutoDock Tools v4<a href="#CIT0017"><sup>17</sup></a>. Gasteiger charges were added and AutoDock v4.0 type atoms were assigned to the protein. Then, test compounds were randomly docked into the protein structure with AutoDock v4.0 using a hybrid Lamarckian Genetic Algorithm<a href="#CIT0018"><sup>18</sup></a>, with an initial population size of 150 and a maximum number of 2,500,000 energy evaluations. The grid box was set to cover the entire protein with a spacing of 0.375â€‰Ã…. The root mean square deviation (RMSD) tolerance was set to 2.0â€‰Ã… for the clustering of docked results and the docked pose of each ligand was selected on the basis of free energy of binding and cluster analysis. Ligandâ€"protein interactions were analysed using Discovery Studio v3.1 and PoseView<a href="#CIT0019"><sup>19</sup></a>.</p> </div> </div> <div class="results" title="results"> <div class="title" tagx="title" title="title">
Results and discussion</div> <div class="designstrategy" title="sec"> <div class="title" tagx="title" title="title">
Design strategy</div> <p>Docking of the corresponding 2â€²-hydroxy-4â€²,6â€²-dimethoxy-4-bromochalcone (<a href="#F0001">Figure 1</a>) described in our previous work to the crystal structure of the human AChE (PDB ID: 4EY7) reveals room for a possible side-chain extension from the C4 position to engage extra binding interactions<a href="#CIT0014"><sup>14</sup></a>. The docking structure suggests that the indole ring of Trp86 at the bottom of the active site gorge is a perspective binding site by Ï€-cation interaction. Thus, we focussed on a well-established chain extension strategy which involves the incorporation of a tertiary nitrogen functional group linked into the C4 position of 2â€²-hydroxychalcone via a short alkyl chain<a href="#CIT0020"><sup>20</sup></a>. We designed and synthesised a set of 14 target derivatives by varying substituent at the C4 position to increase the potency (<a href="#t0002">Table 2</a>, compounds <b>4aâ€"h</b> and <b>8aâ€"f</b>).</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 1.</span></a></div>   <p>Design strategy for 2â€²-hydroxychalcones with modified C4-substituents.</p>   </div> </div> <div class="chemistry" title="sec"> <div class="title" tagx="title" title="title">
Chemistry</div> <p>The syntheses of target derivatives are outlined in <a href="#SCH0001">Scheme 1</a>. The amide coupling between 4-(hydroxymethyl)phenylacetic acid <b>1</b> and the corresponding amine was conducted under the standard carbodiimide chemistry afforded compound <b>2</b>, which was further oxidised to benzaldehyde <b>3</b> with periodinane. The 2â€²-hydroxychalcone derivatives <b>4aâ€"h</b> were obtained from the Claisen-Schmidt condensation of different substituted 2â€²-hydroxyacetophenones and benzaldehyde <b>3</b> in the presence of NaOH in methanol<a href="#CIT0014"><sup>14</sup></a>. Compound <b>7</b> was synthesised in a similar fashion by using different substituted 2â€²-hydroxyacetophenones and methoxymethyl ether (MOM) protected benzaldehyde <b>6</b>. Finally, compounds <b>8aâ€"f</b> were generated from compound <b>7</b> with 1-(2-chloroethyl)piperidine hydrochloride or 1-(2-chloroethyl)pyrrolidine hydrochloride in the presence of Cs<sub>2</sub>CO<sub>3</sub> and NaI<a href="#CIT0021"><sup>21</sup></a>. All target compounds <b>4aâ€"h</b> and <b>8aâ€"f</b> were purified by silica gel chromatography. Their structures were confirmed by using nuclear magnetic resonance spectroscopy (<sup>1</sup>H NMR, <sup>13</sup>C NMR) and high-resolution mass spectrometry (HRMS). Representative spectroscopic spectra are provided in the <a href="https://doi.org/10.1080/14756366.2020.1847100">supplemental data</a>.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Scheme 1.</span></a></div>   <p>Syntheses of tertiary nitrogen-bearing 2â€²-hydroxychalcones. Reaction conditions: (a) EDC, HOBt, R<sub>1</sub>NH, CH<sub>2</sub>Cl<sub>2</sub>, 18â€‰h, 28â€‰Â°C (b) Dess-Martin periodinane, CH<sub>2</sub>Cl<sub>2</sub>, 18â€‰h, 28â€‰Â°C (c) 2â€²-hydroxyacetophenone, 50% aqueous NaOH, MeOH, 24â€‰h, 28â€‰Â°C (d) MOM-Cl, Et<sub>3</sub>N, CH<sub>2</sub>Cl<sub>2</sub>, 4â€‰h, 28â€‰Â°C (e) 1â€‰M HCl, MeOH, 2â€‰h, 60â€‰Â°C (f) 1-(2-chloroethyl)piperidineâ‹…HCl or 1-(2-chloroethyl)pyrrolidineâ‹…HCl, Cs<sub>2</sub>CO<sub>3</sub>, NaI, acetone, 24â€‰h, 60â€‰Â°C.</p>   </div> </div> <div class="admetparameters" title="sec"> <div class="title" tagx="title" title="title">
ADMET parameters</div> <p>The predicted ADMET parameters of designed compounds <b>4aâ€"h</b> and <b>8aâ€"f</b> are summarised in <a href="#t0001">Table 1</a>. According to the ADMET analysis, all the compounds follow Lipinskiâ€™s rule by causing no violation<a href="#CIT0022"><sup>22â€"24</sup></a>. Compounds <b>4g</b> and <b>4h</b> are predicted by the SwissADME to be unable to cross the bloodâ€"brain barrier<a href="#CIT0015"><sup>15</sup></a>. Despite the designed compounds are moderately soluble in water, they have a high degree of gastrointestinal absorption. This may be due to the presence of tertiary nitrogen atom in these compounds that allow the formation of salt, resulting in improved solubility and gastrointestinal adsorption.</p> <div class="table-wrap_UNKNOWN" id="t0001" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 1.</span> <p>ADMET parameters for 2â€²-hydroxychalcones <b>4aâ€"h</b> and <b>8aâ€"f</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup>  <thead> <tr> <th align="left">Compound</th> <th align="center">MW</th> <th align="center">HBD</th> <th align="center">HBA</th> <th align="center">Log P</th> <th align="center">PSA(Ã…<sup>2</sup>)</th> <th align="center">AS</th> <th align="center">GIA</th> <th align="center">BBB</th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>4a</b></td> <td align="char" char=".">367.44</td> <td align="char" char=".">1</td> <td align="char" char=".">4</td> <td align="char" char=".">3.59</td> <td align="char" char=".">67.70</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>4b</b></td> <td align="char" char=".">397.46</td> <td align="char" char=".">1</td> <td align="char" char=".">5</td> <td align="char" char=".">3.57</td> <td align="char" char=".">76.63</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>4c</b></td> <td align="char" char=".">397.46</td> <td align="char" char=".">1</td> <td align="char" char=".">5</td> <td align="char" char=".">3.57</td> <td align="char" char=".">76.63</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>4d</b></td> <td align="char" char=".">365.42</td> <td align="char" char=".">1</td> <td align="char" char=".">4</td> <td align="char" char=".">3.35</td> <td align="char" char=".">67.70</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>4e</b></td> <td align="char" char=".">395.45</td> <td align="char" char=".">1</td> <td align="char" char=".">5</td> <td align="char" char=".">3.34</td> <td align="char" char=".">76.63</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>4f</b></td> <td align="char" char=".">282.29</td> <td align="char" char=".">2</td> <td align="char" char=".">4</td> <td align="char" char=".">3.12</td> <td align="char" char=".">76.23</td> <td align="left">Soluble</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>4g</b></td> <td align="char" char=".">312.32</td> <td align="char" char=".">2</td> <td align="char" char=".">5</td> <td align="char" char=".">3.11</td> <td align="char" char=".">85.16</td> <td align="left">Soluble</td> <td align="left">High</td> <td align="left">No</td> </tr> <tr> <td align="left"><b>4h</b></td> <td align="char" char=".">342.34</td> <td align="char" char=".">2</td> <td align="char" char=".">6</td> <td align="char" char=".">3.09</td> <td align="char" char=".">94.10</td> <td align="left">Soluble</td> <td align="left">High</td> <td align="left">No</td> </tr> <tr> <td align="left"><b>8a</b></td> <td align="char" char=".">381.46</td> <td align="char" char=".">1</td> <td align="char" char=".">5</td> <td align="char" char=".">4.48</td> <td align="char" char=".">59.33</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>8b</b></td> <td align="char" char=".">367.44</td> <td align="char" char=".">1</td> <td align="char" char=".">5</td> <td align="char" char=".">4.03</td> <td align="char" char=".">59.33</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>8c</b></td> <td align="char" char=".">411.49</td> <td align="char" char=".">1</td> <td align="char" char=".">6</td> <td align="char" char=".">4.47</td> <td align="char" char=".">68.26</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>8d</b></td> <td align="char" char=".">397.46</td> <td align="char" char=".">1</td> <td align="char" char=".">6</td> <td align="char" char=".">4.01</td> <td align="char" char=".">68.26</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>8e</b></td> <td align="char" char=".">411.49</td> <td align="char" char=".">1</td> <td align="char" char=".">6</td> <td align="char" char=".">4.47</td> <td align="char" char=".">68.26</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left"><b>8f</b></td> <td align="char" char=".">397.46</td> <td align="char" char=".">1</td> <td align="char" char=".">6</td> <td align="char" char=".">4.01</td> <td align="char" char=".">68.26</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left">Donepezil</td> <td align="char" char=".">379.49</td> <td align="char" char=".">0</td> <td align="char" char=".">4</td> <td align="char" char=".">4.57</td> <td align="char" char=".">38.51</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> <tr> <td align="left">Propidium</td> <td align="char" char=".">414.59</td> <td align="char" char=".">2</td> <td align="char" char=".">2</td> <td align="char" char=".">3.40</td> <td align="char" char=".">58.43</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">No</td> </tr> <tr> <td align="left">Tacrine</td> <td align="char" char=".">198.26</td> <td align="char" char=".">1</td> <td align="char" char=".">2</td> <td align="char" char=".">2.79</td> <td align="char" char=".">37.80</td> <td align="left">Moderate</td> <td align="left">High</td> <td align="left">Yes</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p>MW: molecular weight; HBD: number of hydrogen bond donors; HBA: number of hydrogen bond acceptors; log P: logarithm of octanolâ€"water partition coefficient; PSA: polar surface area. AS: aqueous solubility; GIA: gastrointestinal absorption; BBB: bloodâ€"brain barrier.</p> </div> </div> </div> </div> <div class="cholinesteraseinhibitoryactivity" title="sec"> <div class="title" tagx="title" title="title">
Cholinesterase inhibitory activity</div> <p>The designed 2â€²-hydroxychalcone derivatives were evaluated for their <i>inÂ vitro</i> inhibitory activities against human recombinant AChE according to Ellmanâ€™s colorimetric assay method<a href="#CIT0016"><sup>16</sup></a>. The results are summarised in <a href="#t0002">Table 2</a>. Most of the tested compounds showed promising AChE inhibitory activity when screened at 10â€‰ÂµM. Based on the structureâ€"activity relationship analysis, it is clear that AChE inhibitory activity was closely related to the C4-substituent. Generally, the tertiary amine substituted compounds possessed better AChE inhibitory activity than that of tertiary amide substituted compounds. The results of <b>8a</b>, <b>8â€‰b</b>, and <b>8dâ€"f</b> demonstrated that compounds with piperidine or pyrrolidine substituted at C4 position were comparably potent as that of donepezil and tacrine against AChE. When examining the efficacy of compounds <b>4aâ€"e</b>, the presence of 6â€²-methoxy substituent in the A ring favour the AChE activity. Compounds <b>4fâ€"h</b> which lack of a tertiary nitrogen substituent in B ring were inactive, indicating that the carboxylic group is not favoured for interaction. Besides, the length of the C4 side chain also played a significant role in the AChE inhibitory activity. Tertiary amine-bearing derivatives <b>8aâ€"f</b> which contain a side chain of 2 carbon atoms, displayed a better inhibition than those derivatives without side chain described in our previous work<a href="#CIT0014"><sup>14</sup></a>.</p> <p>Subsequently, IC<sub>50</sub> experiments were carried out for compounds <b>4c</b>, <b>8a</b>, <b>8â€‰b</b>, and <b>8dâ€"f</b> against human AChE and equine BuChE. The latter is considered a good model for human BuChE due to its high sequence similarity to the human form (90% sequence identity)<a href="#CIT0025"><sup>25</sup></a>. The IC<sub>50</sub> values are included in <a href="#t0003">Table 3</a>. Generally, these compounds showed higher activity towards AChE with IC<sub>50</sub> values in the range of 3â€"19â€‰ÂµM. Among the target derivatives, compound <b>4c</b> was the most active towards AChE with IC<sub>50</sub> = 3.3â€‰ÂµM. Moreover, compound <b>4c</b> exhibited the highest selectivity for AChE over BuChE (SI &amp;gt;30). High AChE selectivity over BuChE (SI &amp;gt;24) was also observed for compound <b>8a</b>, which possesses a piperidinyl ethyl ether substituted at the C4 position. Studies have shown that high AChE selectivity over BuChE may reduce the associated side effects of AD treatment<a href="#CIT0026"><sup>26</sup></a>. Hence, compounds with high AChE selectivity over BuChE may be clinically useful. As can be seen in <a href="#t0003">Table 3</a>, the designed compounds generally showed lower BuChE inhibitory activity as compared to that of AChE. Compound <b>8e</b> was the most active towards BuChE with IC<sub>50</sub> = 18.3â€‰Î¼M. In comparison, compound <b>8a</b> which lack of a 6â€²-methoxy substituent in the A ring was inactive, indicating that the 6â€²-methoxy group is important for interaction.</p> <div class="table-wrap_UNKNOWN" id="t0002" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 2.</span> <p>Substituent patterns and human acetylcholinesterase inhibitory activity of 2â€²-hydroxychalcones <b>4aâ€"h</b> and <b>8aâ€"f</b>.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup>  <thead> <tr> <th align="left">Compound</th> <th align="center">Structure</th> <th align="center">Human AChE (% Inhibition at 10â€‰Î¼M)<sup>a</sup></th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>4a</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">67.2</td> </tr> <tr> <td align="left"><b>4b</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">58.5</td> </tr> <tr> <td align="left"><b>4c</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">87.5</td> </tr> <tr> <td align="left"><b>4d</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">30.8</td> </tr> <tr> <td align="left"><b>4e</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">58.9</td> </tr> <tr> <td align="left"><b>4f</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">10.7</td> </tr> <tr> <td align="left"><b>4g</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">27.0</td> </tr> <tr> <td align="left"><b>4h</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">15.6</td> </tr> <tr> <td align="left"><b>8a</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">79.9</td> </tr> <tr> <td align="left"><b>8b</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">83.0</td> </tr> <tr> <td align="left"><b>8c</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">52.5</td> </tr> <tr> <td align="left"><b>8d</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">80.6</td> </tr> <tr> <td align="left"><b>8e</b></td> <td align="char" char="."><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">83.6</td> </tr> <tr> <td align="left"><b>8f</b></td> <td align="center"><span class="inline-graphic" title="inline-graphic" /></td> <td align="char" char=".">81.4</td> </tr> <tr> <td align="left">Donepezil<sup>b</sup></td> <td align="char" char=".">Â </td> <td align="char" char=".">92.0</td> </tr> <tr> <td align="left">Propidium<sup>c</sup></td> <td align="char" char=".">Â </td> <td align="char" char=".">52.0</td> </tr> <tr> <td align="left">Tacrine<sup>d</sup></td> <td align="char" char=".">Â </td> <td align="char" char=".">89.0</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p><sup>a</sup>Values are expressed as mean of triplicate; <sup>b</sup>standard PAS and CAS-binding AChE inhibitor; <sup>c</sup>standard PAS-binding AChE inhibitor; <sup>d</sup>standard CAS-binding AChE inhibitor.</p> </div> </div> </div> <div class="table-wrap_UNKNOWN" id="t0003" orientation="portrait" position="float"><span class="label" tagx="label" title="label">Table 3.</span> <p>Human AChE and equine BuChE inhibitory activities of the most active tertiary nitrogen containing 2â€²-hydroxychalcones.</p>  <table frame="hsides" rules="groups"> <colgroup> <col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup> <colgroup><col width="1*" /></colgroup>  <thead> <tr> <th align="left">Compound</th> <th align="center">Human AChE<br /><br />IC<sub>50</sub>/ÂµM<sup>a</sup></th> <th align="center">Equine BuChE<br /><br />IC<sub>50</sub>/ÂµM<sup>a</sup></th> <th align="center">Selectivity index<sup>b</sup></th> </tr> </thead> <tbody valign="top"> <tr> <td align="left"><b>4c</b></td> <td align="char" char="Â±">3.3â€‰Â±â€‰1.3</td> <td align="center">&amp;gt;100</td> <td align="center">&amp;gt;30</td> </tr> <tr> <td align="left"><b>8a</b></td> <td align="char" char="Â±">4.2â€‰Â±â€‰1.3</td> <td align="center">&amp;gt;100</td> <td align="center">&amp;gt;24</td> </tr> <tr> <td align="left"><b>8b</b></td> <td align="char" char="Â±">12.8â€‰Â±â€‰4.8</td> <td align="char" char="Â±">65.6â€‰Â±â€‰14.8</td> <td align="char" char=".">5.1</td> </tr> <tr> <td align="left"><b>8d</b></td> <td align="char" char="Â±">15.9â€‰Â±â€‰1.8</td> <td align="char" char="Â±">89.9â€‰Â±â€‰12.0</td> <td align="char" char=".">5.7</td> </tr> <tr> <td align="left"><b>8e</b></td> <td align="char" char="Â±">4.6â€‰Â±â€‰0.9</td> <td align="char" char="Â±">18.3â€‰Â±â€‰8.0</td> <td align="char" char=".">4.0</td> </tr> <tr> <td align="left"><b>8f</b></td> <td align="char" char="Â±">18.5â€‰Â±â€‰3.8</td> <td align="char" char="Â±">31.3â€‰Â±â€‰8.2</td> <td align="char" char=".">1.7</td> </tr> <tr> <td align="left">Donepezil<sup>c</sup></td> <td align="char" char="Â±">0.09â€‰Â±â€‰0.01</td> <td align="char" char="Â±">1.9â€‰Â±â€‰0.2</td> <td align="center">21</td> </tr> <tr> <td align="left">Propidium<sup>d</sup></td> <td align="char" char="Â±">11â€‰Â±â€‰3</td> <td align="char" char="Â±">20.8â€‰Â±â€‰2.1</td> <td align="char" char=".">1.9</td> </tr> <tr> <td align="left">Tacrine<sup>e</sup></td> <td align="char" char="Â±">0.19â€‰Â±â€‰0.04</td> <td align="char" char="Â±">0.011â€‰Â±â€‰0.001</td> <td align="char" char=".">0.06</td> </tr> </tbody> </table> <div class="table-wrap-foot_UNKNOWN"> <div class="fn-type-" title=""> <p><sup>a</sup>Values are expressed as mean of triplicate; <sup>b</sup>Selectivity indexâ€‰=â€‰IC<sub>50</sub> (BuChE)/IC<sub>50</sub> (AChE); <sup>c</sup>Standard PAS and CAS-binding AChE inhibitor; <sup>d</sup>Standard PAS-binding AChE inhibitor; <sup>e</sup>Standard CAS-binding AChE inhibitor.</p> </div> </div> </div> </div> <div class="moleculardocking" title="sec"> <div class="title" tagx="title" title="title">
Molecular docking</div> <p>The most active compounds <b>4c</b>, <b>8a</b>, and <b>8e</b> were docked into an AChE model obtained from the X-ray crystal structure of human AChE in complex with donepezil (PDB ID: 4EY7)<a href="#CIT0002"><sup>2</sup></a> in order to study the proteinâ€"ligand binding interactions.</p> <p>All docked compounds were found to exhibit binding poses similar to those of donepezil occupying both the peripheral anionic site (PAS) and catalytic anionic site (CAS) of the AChE (<a href="#F0002">Figure 2)</a>. It was observed that the aromatic ring A of compounds <b>4c</b> and <b>8e</b> formed Ï€â€"Ï€ stacking interactions with the PAS residue, Trp286, whereas aromatic ring B of compound <b>8a</b> formed Ï€â€"Ï€ stacking interactions with Tyr341 (at the entrance to the gorge leading to that CAS). In the case of compounds <b>4c</b> and <b>8a</b>, the carbonyl oxygen atom and the <i>ortho</i>-hydroxyl group on the A ring were observed to form hydrogen bonds with backbone atoms from acyl pocket residues, Phe295 and Arg296, respectively. This may be one of the reasons to account for the greater activity of these two compounds, as compound <b>8e</b> only interacted with Arg296. The positively-charged nitrogen atom of the piperidine ring in compound <b>8a</b> formed Ï€â€"cation interaction with CAS site aromatic residue, Trp86. This interaction is particularly important as several studies have reported its implication for biological recognition of human AChE<a href="#CIT0027"><sup>27</sup></a><sup>,</sup><a href="#CIT0028"><sup>28</sup></a>. In the case of compound <b>8e</b>, an extra hydrogen bonding interaction was formed between the ether oxygen atom and residue Tyr337. Taken together, these interactions have contributed to the enhanced potency of 2â€²-hydroxychalcone with modified C4-substituents. The docking findings are in agreement with the experimental results and provide reasons for improved cholinesterase inhibitory activity of the designed derivatives.</p> <div class="fig" title="fig"> <div class="figure" title="figure"><a href="http://doi.org/"><span class="label" tagx="label" title="label">Figure 2.</span></a></div>   <p>Representations of compounds <b>4c</b> (A, B), <b>8a</b> (C, D), and <b>8e</b> (E, F) in complex with human AChE (PDB ID: 4EY7). (A, C, and E) 3D representations of the binding pose. The hydrophobic surfaces of the interacting residues are shown in blue relief. Hydrogen bonds and Ï€â€"cation interactions are depicted with green and orange dotted lines, respectively; (B, D, and F) Schematic representations of the binding interactions. Hydrogen bonds and Ï€â€"Ï€ stacking interactions are depicted with black and green dotted lines, respectively. The green curve represents other non-polar interactions.</p>   </div> </div> </div> <div class="conclusions" title="conclusions"> <div class="title" tagx="title" title="title">
Conclusions</div> <p>In conclusion, novel 2â€²-hydroxychalcone derivatives with modified C4-substituents were designed, synthesised and evaluated as inhibitors of human AChE. Compounds with methoxy substituents on the A ring and piperidinyl ethyl ether substituent on B ring were generally found to be more potent. Molecular docking studies have suggested that these compounds interact with both the PAS and CAS regions of AChE. The most active 2â€²-hydroxychalcones showed high AChE selectivity over BuChE, suggesting that these compounds may be suitable to be developed into clinically useful drug candidates.</p> </div> <div class="authorsâ€™contributions" title="sec"> <div class="title" tagx="title" title="title">
Authorsâ€™ contributions</div> <p>S.D.S: biological evaluation, chemical synthesis, molecular modelling, and manuscript drafting.Â T.J.T, S.B.N.: chemical synthesis. C.F.C., M.J.C.B.: project design, data analysis, manuscript preparation and revision. S.N.A.B.: interpretation of data and manuscript revision.Â R.O., N.A.R, and V. S. L: Project conception, design and co-ordination.Â All authors have read and approved the final version of the manuscript.</p> </div> <div class="supplementary-material" title="supplementary-material"> <div class="title" tagx="title" title="title">
Supplementary Material</div> <div class="local-data" title="local-data">  <div class="title" tagx="title" title="title">
Supplemental Material</div>  <div class="media" title="media"><a href="IENZ_A_1847100_SM6445.pdf">LINK</a> <p>Click here for additional data file.</p>  </div> </div> </div> </div> <div class="back" title="back"> <div class="COI-statement" title="COI-statement"> <div class="title" tagx="title" title="title">
Disclosure statement</div> <p>No potential conflict of interest was reported by the author(s).</p> </div> <div class="data-availability" title="data-availability"> <div class="title" tagx="title" title="title">
Data availability statement</div> <p>The raw data supporting the conclusions of this manuscript will be made available by the authors, without undue reservation, to any qualified researcher.</p> </div> <div class="references">
References</div> <div tag="ref-list"> <ul> <div class="title" tagx="title" title="title">
References</div> <li tag="ref"><a name="CIT0001" /><span class="label" tagx="label" title="label">1</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="collab'">collab: Alzheimer's Association</span></span><span class="mixed-article-title" title="mixed-article-title">2018 Alzheimerâ€™s disease facts and figures</span>. <span class="source" tagx="source" title="source">Alzheimers Dement</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">14</span>:<span class="fpage" tagx="fpage" title="fpage">367</span>â€"<span class="lpage" tagx="lpage" title="lpage">425</span>.</span></li> <li tag="ref"><a name="CIT0002" /><span class="label" tagx="label" title="label">2</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cheung</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rudolph</span><span class="given-names" tagx="given-names" title="given-names">MJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Burshteyn</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Structures of human acetylcholinesterase in complex with pharmacologically important ligands</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">55</span>:<span class="fpage" tagx="fpage" title="fpage">10282</span>â€"<span class="lpage" tagx="lpage" title="lpage">6</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23035744">23035744</a></span></span></li> <li tag="ref"><a name="CIT0003" /><span class="label" tagx="label" title="label">3</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">van Greunen</span><span class="given-names" tagx="given-names" title="given-names">DG</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cordier</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nell</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Targeting Alzheimerâ€™s disease by investigating previously unexplored chemical space surrounding the cholinesterase inhibitor donepezil</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">127</span>:<span class="fpage" tagx="fpage" title="fpage">671</span>â€"<span class="lpage" tagx="lpage" title="lpage">90</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27823887">27823887</a></span></span></li> <li tag="ref"><a name="CIT0004" /><span class="label" tagx="label" title="label">4</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Peauger</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Azzouz</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gembus</span><span class="given-names" tagx="given-names" title="given-names">V</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Donepezil-based central acetylcholinesterase inhibitors by means of a â€œbio-oxidizableâ€� prodrug strategy: design, synthesis, and inÂ vitro biological evaluation</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">60</span>:<span class="fpage" tagx="fpage" title="fpage">5909</span>â€"<span class="lpage" tagx="lpage" title="lpage">26</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28613859">28613859</a></span></span></li> <li tag="ref"><a name="CIT0005" /><span class="label" tagx="label" title="label">5</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lan</span><span class="given-names" tagx="given-names" title="given-names">JS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">T</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design, synthesis and biological activity of novel donepezil derivatives bearing n-benzyl pyridinium moiety as potent and dual binding site acetylcholinesterase inhibitors</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">133</span>:<span class="fpage" tagx="fpage" title="fpage">184</span>â€"<span class="lpage" tagx="lpage" title="lpage">96</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28388521">28388521</a></span></span></li> <li tag="ref"><a name="CIT0006" /><span class="label" tagx="label" title="label">6</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Xie</span><span class="given-names" tagx="given-names" title="given-names">SS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lan</span><span class="given-names" tagx="given-names" title="given-names">JS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">XB</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design, synthesis and biological evaluation of novel donepezil-coumarin hybrids as multi-target agents for the treatment of alzheimerâ€™s disease</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">1528</span>â€"<span class="lpage" tagx="lpage" title="lpage">39</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26917219">26917219</a></span></span></li> <li tag="ref"><a name="CIT0007" /><span class="label" tagx="label" title="label">7</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">ZM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cai</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">QH</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Rational modification of donepezil as multifunctional acetylcholinesterase inhibitors for the treatment of alzheimerâ€™s disease</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">123</span>:<span class="fpage" tagx="fpage" title="fpage">282</span>â€"<span class="lpage" tagx="lpage" title="lpage">97</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27484514">27484514</a></span></span></li> <li tag="ref"><a name="CIT0008" /><span class="label" tagx="label" title="label">8</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wang</span><span class="given-names" tagx="given-names" title="given-names">ZM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wu</span><span class="given-names" tagx="given-names" title="given-names">JJ</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis and pharmacological evaluation of donepezil-based agents as new cholinesterase/monoamine oxidase inhibitors for the potential application against alzheimerâ€™s disease</span>. <span class="source" tagx="source" title="source">J Enzym Inhib Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">31</span>:<span class="fpage" tagx="fpage" title="fpage">41</span>â€"<span class="lpage" tagx="lpage" title="lpage">53</span>.</span></li> <li tag="ref"><a name="CIT0009" /><span class="label" tagx="label" title="label">9</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huang</span><span class="given-names" tagx="given-names" title="given-names">CS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Tu</span><span class="given-names" tagx="given-names" title="given-names">WT</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">M</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Shi</span><span class="given-names" tagx="given-names" title="given-names">JC.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular docking and design of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors</span>. <span class="source" tagx="source" title="source">Chin J Struct Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">35</span>:<span class="fpage" tagx="fpage" title="fpage">839</span>â€"<span class="lpage" tagx="lpage" title="lpage">48</span>.</span></li> <li tag="ref"><a name="CIT0010" /><span class="label" tagx="label" title="label">10</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Costanzo</span><span class="given-names" tagx="given-names" title="given-names">P</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Cariati</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Desiderio</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design, synthesis, and evaluation of donepezil-like compounds as ache and bace-1 inhibitors</span>. <span class="source" tagx="source" title="source">ACS Med Chem Lett</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">470</span>â€"<span class="lpage" tagx="lpage" title="lpage">5</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27190595">27190595</a></span></span></li> <li tag="ref"><a name="CIT0011" /><span class="label" tagx="label" title="label">11</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Desiderio</span><span class="given-names" tagx="given-names" title="given-names">D</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lamberti</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Roberta</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Donepezil analogs as acetylcholinesterase inhibitors</span>. <span class="source" tagx="source" title="source">FEBS J</span><span class="year" tagx="year" title="year">2014</span>;<span class="volume" tagx="volume" title="volume">281</span>:<span class="fpage" tagx="fpage" title="fpage">557</span>.</span></li> <li tag="ref"><a name="CIT0012" /><span class="label" tagx="label" title="label">12</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Hu</span><span class="given-names" tagx="given-names" title="given-names">YQ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhang</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chandrashankra</span><span class="given-names" tagx="given-names" title="given-names">O</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Design, synthesis and evaluation of novel heterodimers of donepezil and huperzine fragments as acetylcholinesterase inhibitors</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">676</span>â€"<span class="lpage" tagx="lpage" title="lpage">83</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23273608">23273608</a></span></span></li> <li tag="ref"><a name="CIT0013" /><span class="label" tagx="label" title="label">13</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ismail</span><span class="given-names" tagx="given-names" title="given-names">MM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kamel</span><span class="given-names" tagx="given-names" title="given-names">MM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Mohamed</span><span class="given-names" tagx="given-names" title="given-names">LW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Faggal</span><span class="given-names" tagx="given-names" title="given-names">SI.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis of new indole derivatives structurally related to donepezil and their biological evaluation as acetylcholinesterase inhibitors</span>. <span class="source" tagx="source" title="source">Molecules</span><span class="year" tagx="year" title="year">2012</span>;<span class="volume" tagx="volume" title="volume">17</span>:<span class="fpage" tagx="fpage" title="fpage">4811</span>â€"<span class="lpage" tagx="lpage" title="lpage">23</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/22534665">22534665</a></span></span></li> <li tag="ref"><a name="CIT0014" /><span class="label" tagx="label" title="label">14</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sukumaran</span><span class="given-names" tagx="given-names" title="given-names">SD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chee</span><span class="given-names" tagx="given-names" title="given-names">CF</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Viswanathan</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Synthesis, biological evaluation and molecular modelling of 2-hydroxychalcones as acetylcholinesterase inhibitors</span>. <span class="source" tagx="source" title="source">Molecules</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">21</span>:<span class="fpage" tagx="fpage" title="fpage">955</span>.</span></li> <li tag="ref"><a name="CIT0015" /><span class="label" tagx="label" title="label">15</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Daina</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Michielin</span><span class="given-names" tagx="given-names" title="given-names">O</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zoete</span><span class="given-names" tagx="given-names" title="given-names">V.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Swissadme: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules</span>. <span class="source" tagx="source" title="source">Sci Rep</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">42717</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/28256516">28256516</a></span></span></li> <li tag="ref"><a name="CIT0016" /><span class="label" tagx="label" title="label">16</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ellman</span><span class="given-names" tagx="given-names" title="given-names">GL</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Courtney</span><span class="given-names" tagx="given-names" title="given-names">KD</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Andres</span><span class="given-names" tagx="given-names" title="given-names">V</span><span class="suffix" tagx="suffix" title="suffix">Jr.</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feather-Stone</span><span class="given-names" tagx="given-names" title="given-names">RM.</span></span></span><span class="mixed-article-title" title="mixed-article-title">A new and rapid colorimetric determination of acetylcholinesterase activity</span>. <span class="source" tagx="source" title="source">Biochem Pharmacol</span><span class="year" tagx="year" title="year">1961</span>;<span class="volume" tagx="volume" title="volume">7</span>:<span class="fpage" tagx="fpage" title="fpage">88</span>â€"<span class="lpage" tagx="lpage" title="lpage">95</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/13726518">13726518</a></span></span></li> <li tag="ref"><a name="CIT0017" /><span class="label" tagx="label" title="label">17</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morris</span><span class="given-names" tagx="given-names" title="given-names">GM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Huey</span><span class="given-names" tagx="given-names" title="given-names">R</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lindstrom</span><span class="given-names" tagx="given-names" title="given-names">W</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility</span>. <span class="source" tagx="source" title="source">J Comput Chem</span><span class="year" tagx="year" title="year">2009</span>;<span class="volume" tagx="volume" title="volume">30</span>:<span class="fpage" tagx="fpage" title="fpage">2785</span>â€"<span class="lpage" tagx="lpage" title="lpage">91</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/19399780">19399780</a></span></span></li> <li tag="ref"><a name="CIT0018" /><span class="label" tagx="label" title="label">18</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Morris</span><span class="given-names" tagx="given-names" title="given-names">GM</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Goodsell</span><span class="given-names" tagx="given-names" title="given-names">DS</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Halliday</span><span class="given-names" tagx="given-names" title="given-names">RS</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Automated docking using a Lamarckian genetic algorithm and empirical binding free energy function</span>. <span class="source" tagx="source" title="source">J Comput Chem</span><span class="year" tagx="year" title="year">1998</span>;<span class="volume" tagx="volume" title="volume">19</span>:<span class="fpage" tagx="fpage" title="fpage">1639</span>â€"<span class="lpage" tagx="lpage" title="lpage">62</span>.</span></li> <li tag="ref"><a name="CIT0019" /><span class="label" tagx="label" title="label">19</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Stierand</span><span class="given-names" tagx="given-names" title="given-names">K</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Maass</span><span class="given-names" tagx="given-names" title="given-names">PC</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Rarey</span><span class="given-names" tagx="given-names" title="given-names">M.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Molecular complexes at a glance: automated generation of two-dimensional complex diagrams</span>. <span class="source" tagx="source" title="source">Bioinform</span><span class="year" tagx="year" title="year">2006</span>;<span class="volume" tagx="volume" title="volume">22</span>:<span class="fpage" tagx="fpage" title="fpage">1710</span>â€"<span class="lpage" tagx="lpage" title="lpage">16</span>.</span></li> <li tag="ref"><a name="CIT0020" /><span class="label" tagx="label" title="label">20</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Leong</span><span class="given-names" tagx="given-names" title="given-names">SW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Abas</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lam</span><span class="given-names" tagx="given-names" title="given-names">KW</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">2-benzoyl-6-benzylidenecyclohexanone analogs as potent dual inhibitors of acetylcholinesterase and butyrylcholinesterase</span>. <span class="source" tagx="source" title="source">Bioorg Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">24</span>:<span class="fpage" tagx="fpage" title="fpage">3742</span>â€"<span class="lpage" tagx="lpage" title="lpage">51</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27328658">27328658</a></span></span></li> <li tag="ref"><a name="CIT0021" /><span class="label" tagx="label" title="label">21</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Gao</span><span class="given-names" tagx="given-names" title="given-names">XH</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Zhou</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Liu</span><span class="given-names" tagx="given-names" title="given-names">HR</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Tertiary amine derivatives of chlorochalcone as acetylcholinesterase (ache) and buthylcholinesterase (buche) inhibitors: the influence of chlorine, alkyl amine side chain and Î±,Î²-unsaturated ketone group</span>. <span class="source" tagx="source" title="source">J Enzyme Inhib Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">32</span>:<span class="fpage" tagx="fpage" title="fpage">146</span>â€"<span class="lpage" tagx="lpage" title="lpage">52</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27801600">27801600</a></span></span></li> <li tag="ref"><a name="CIT0022" /><span class="label" tagx="label" title="label">22</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lipinski</span><span class="given-names" tagx="given-names" title="given-names">CA</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Lombardo</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Dominy</span><span class="given-names" tagx="given-names" title="given-names">BW</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Feeney</span><span class="given-names" tagx="given-names" title="given-names">PJ.</span></span></span><span class="mixed-article-title" title="mixed-article-title">Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings</span>. <span class="source" tagx="source" title="source">Adv Drug Deliv Rev</span><span class="year" tagx="year" title="year">1997</span>;<span class="volume" tagx="volume" title="volume">23</span>:<span class="fpage" tagx="fpage" title="fpage">3</span>â€"<span class="lpage" tagx="lpage" title="lpage">25</span>.</span></li> <li tag="ref"><a name="CIT0023" /><span class="label" tagx="label" title="label">23</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kelder</span><span class="given-names" tagx="given-names" title="given-names">J</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Grootenhuis</span><span class="given-names" tagx="given-names" title="given-names">PDJ</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Bayada</span><span class="given-names" tagx="given-names" title="given-names">DM</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Polar molecular surface as a dominating determinant for oral absorption and brain penetration of drugs</span>. <span class="source" tagx="source" title="source">Pharm Res</span><span class="year" tagx="year" title="year">1999</span>;<span class="volume" tagx="volume" title="volume">16</span>:<span class="fpage" tagx="fpage" title="fpage">1514</span>â€"<span class="lpage" tagx="lpage" title="lpage">19</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/10554091">10554091</a></span></span></li> <li tag="ref"><a name="CIT0024" /><span class="label" tagx="label" title="label">24</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Van de Waterbeemd</span><span class="given-names" tagx="given-names" title="given-names">H</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Camenish</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Folkers</span><span class="given-names" tagx="given-names" title="given-names">G</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors</span>. <span class="source" tagx="source" title="source">J Drug Target</span><span class="year" tagx="year" title="year">1998</span>;<span class="volume" tagx="volume" title="volume">6</span>:<span class="fpage" tagx="fpage" title="fpage">151</span>â€"<span class="lpage" tagx="lpage" title="lpage">65</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/9886238">9886238</a></span></span></li> <li tag="ref"><a name="CIT0025" /><span class="label" tagx="label" title="label">25</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Sawatzky</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Wehle</span><span class="given-names" tagx="given-names" title="given-names">S</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Kling</span><span class="given-names" tagx="given-names" title="given-names">B</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Discovery of highly selective and nanomolar carbamate-based butyrylcholinesterase inhibitors by rational investigation into their inhibition mode</span>. <span class="source" tagx="source" title="source">J Med Chem</span><span class="year" tagx="year" title="year">2016</span>;<span class="volume" tagx="volume" title="volume">59</span>:<span class="fpage" tagx="fpage" title="fpage">2067</span>â€"<span class="lpage" tagx="lpage" title="lpage">82</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/26886849">26886849</a></span></span></li> <li tag="ref"><a name="CIT0026" /><span class="label" tagx="label" title="label">26</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Li</span><span class="given-names" tagx="given-names" title="given-names">Y</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Qiang</span><span class="given-names" tagx="given-names" title="given-names">X</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Luo</span><span class="given-names" tagx="given-names" title="given-names">L</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Aurone mannich base derivatives as promising multifunctional agents with acetylcholinesterase inhibition, anti-Î²-amyloid aggragation and neuroprotective properties for the treatment of Alzheimerâ€™s disease</span>. <span class="source" tagx="source" title="source">Eur J Med Chem</span><span class="year" tagx="year" title="year">2017</span>;<span class="volume" tagx="volume" title="volume">126</span>:<span class="fpage" tagx="fpage" title="fpage">762</span>â€"<span class="lpage" tagx="lpage" title="lpage">75</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/27951485">27951485</a></span></span></li> <li tag="ref"><a name="CIT0027" /><span class="label" tagx="label" title="label">27</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ranjan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Chauhan</span><span class="given-names" tagx="given-names" title="given-names">A</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Jindal</span><span class="given-names" tagx="given-names" title="given-names">T.</span></span></span><span class="mixed-article-title" title="mixed-article-title">In-silico and in-vitro evaluation of human acetylcholinesterase inhibition by organophosphates</span>. <span class="source" tagx="source" title="source">Environ Toxicol Pharmacol</span><span class="year" tagx="year" title="year">2018</span>;<span class="volume" tagx="volume" title="volume">57</span>:<span class="fpage" tagx="fpage" title="fpage">131</span>â€"<span class="lpage" tagx="lpage" title="lpage">40</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/29272792">29272792</a></span></span></li> <li tag="ref"><a name="CIT0028" /><span class="label" tagx="label" title="label">28</span><span class="mixed-citation" tagx="mixed-citation" title="mixed-citation"><span class="person-group'"><span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Nachon</span><span class="given-names" tagx="given-names" title="given-names">F</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Carletti</span><span class="given-names" tagx="given-names" title="given-names">E</span></span>, <span class="name" tagx="name" title="name"><span class="surname" tagx="surname" title="surname">Ronco</span><span class="given-names" tagx="given-names" title="given-names">C</span></span>, <span class="etal" title="etal"><i>et al.</i></span></span><span class="mixed-article-title" title="mixed-article-title">Crystal structures of human cholinesterases in complex with huprine w and tacrine: elements of specificity for anti-Alzheimerâ€™s drugs targeting acetyl-and butyryl-cholinesterase</span>. <span class="source" tagx="source" title="source">Biochem J</span><span class="year" tagx="year" title="year">2013</span>;<span class="volume" tagx="volume" title="volume">453</span>:<span class="fpage" tagx="fpage" title="fpage">393</span>â€"<span class="lpage" tagx="lpage" title="lpage">9</span>.<span class="pub-id"><a href="http://www.ncbi.nlm.nih.gov/pubmed/23679855">23679855</a></span></span></li> </ul> </div> </div>  </body></html>